These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1342 related articles for article (PubMed ID: 20618997)
1. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. Mossman D; Kim KT; Scott RJ BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997 [TBL] [Abstract][Full Text] [Related]
2. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. Meng CF; Zhu XJ; Peng G; Dai DQ Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243 [TBL] [Abstract][Full Text] [Related]
3. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation. Mossman D; Scott RJ PLoS One; 2011; 6(8):e23127. PubMed ID: 21829702 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682 [TBL] [Abstract][Full Text] [Related]
6. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. Meng CF; Zhu XJ; Peng G; Dai DQ World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755 [TBL] [Abstract][Full Text] [Related]
7. Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells. Kong Q; Wu M; Wang Z; Zhang X; Li L; Liu X; Mu Y; Liu Z Mol Cell Biochem; 2011 Sep; 355(1-2):157-65. PubMed ID: 21541675 [TBL] [Abstract][Full Text] [Related]
8. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800 [TBL] [Abstract][Full Text] [Related]
9. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer. Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473 [TBL] [Abstract][Full Text] [Related]
10. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735 [TBL] [Abstract][Full Text] [Related]
11. Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. Yamada N; Nishida Y; Tsutsumida H; Goto M; Higashi M; Nomoto M; Yonezawa S Br J Cancer; 2009 Jan; 100(2):344-51. PubMed ID: 19127263 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma. Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234 [TBL] [Abstract][Full Text] [Related]
13. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295 [TBL] [Abstract][Full Text] [Related]
15. Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. Dannenberg LO; Edenberg HJ BMC Genomics; 2006 Jul; 7():181. PubMed ID: 16854234 [TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167 [TBL] [Abstract][Full Text] [Related]
18. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP]. Meng CF; Dai DQ; Guo KJ Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]